Cargando…

The Multiple Sclerosis Severity Score: fluctuations and prognostic ability in a longitudinal cohort of patients with MS

BACKGROUND: The Multiple Sclerosis Severity Score (MSSS), combining the Expanded Disability Status Scale (EDSS) and disease duration, attempts to stratify multiple sclerosis (MS) patients based on their rate of progression. Its prognostic ability in the individual patient remains unproven. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gross, RH, Sillau, SH, Miller, AE, Farrell, C, Krieger, SC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423683/ https://www.ncbi.nlm.nih.gov/pubmed/30911402 http://dx.doi.org/10.1177/2055217319837254

Ejemplares similares

Regarding the publication The Multiple Sclerosis Severity Score: Fluctuations and prognostic ability in a longitudinal cohort of patients with MS authored by RH Gross et al
por: Roxburgh, Richard, et al.
Publicado: (2020)

The Seasonal Fluctuation of Fatigue in Multiple Sclerosis
por: Grothe, Matthias, et al.
Publicado: (2022)

Regarding the letter from Roxburgh, et al.
por: Gross, RH, et al.
Publicado: (2020)

Longitudinal Changes in Self-Reported Walking Ability in Multiple Sclerosis
por: Motl, Robert W., et al.
Publicado: (2015)

Estimating Risk of Multiple Sclerosis Disease Reactivation in Pregnancy and Postpartum: The VIPRiMS Score
por: Bsteh, Gabriel, et al.
Publicado: (2022)

Smouldering multiple sclerosis: the ‘real MS’
por: Giovannoni, Gavin, et al.
Publicado: (2022)

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
por: Vollmer, Brandi L., et al.
Publicado: (2018)

Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment
por: Vollmer, Brandi L., et al.
Publicado: (2020)

Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience
por: Vollmer, Brandi, et al.
Publicado: (2017)

The immunoregulatory abilities of polymorphonuclear neutrophils in multiple sclerosis.
por: Mayer, M
Publicado: (1999)

Strengthening Mental Abilities with Relational Training (SMART) in multiple sclerosis (MS): study protocol for a feasibility randomised controlled trial
por: Golijani-Moghaddam, Nima, et al.
Publicado: (2022)

Decline of Neuropsychological Abilities in a Large Sample of Patients with Multiple Sclerosis: A Two-Year Longitudinal Study
por: Borghi, Martina, et al.
Publicado: (2016)

Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS)
por: GHAJARZADEH, Mahsa, et al.
Publicado: (2014)

Stepchild or Prodigy? Neuroprotection in Multiple Sclerosis (MS) Research
por: Rottlaender, Andrea, et al.
Publicado: (2015)

Prevalence of Multiple Sclerosis (MS) in Zanjan Province of Iran
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS)
por: De Bondt, Mirre, et al.
Publicado: (2020)

Multiple Sclerosis
por: Ramagopalan, Sreeram, et al.
Publicado: (2011)

The immunoregulatory abilities of polymorphonuclear neutrophils in the course of multiple sclerosis.
por: Ziaber, J, et al.
Publicado: (1998)

Discriminative ability of quality of life measures in multiple sclerosis
por: Fiest, Kirsten M., et al.
Publicado: (2017)

Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis
por: Raskin, Eyal, et al.
Publicado: (2022)

Longitudinal study of alexithymia and multiple sclerosis
por: Chahraoui, Khadija, et al.
Publicado: (2014)

Stability of Mental Toughness, Sleep Disturbances, and Physical Activity in Patients With Multiple Sclerosis (MS)—A Longitudinal and Pilot Study
por: Sadeghi Bahmani, Dena, et al.
Publicado: (2018)

Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis
por: Vollmer, Brandi L., et al.
Publicado: (2022)

Longitudinal multiplicity fluctuations and flow decorrelations in Pb+Pb collisions with the ATLAS detector
por: Derendarz, Dominik
Publicado: (2017)

A novel prognostic score to assess the risk of progression in relapsing−remitting multiple sclerosis patients
por: Pisani, Anna Isabella, et al.
Publicado: (2021)

The Causal Cascade to Multiple Sclerosis: A Model for MS Pathogenesis
por: Goodin, Douglas S.
Publicado: (2009)

The genetic basis of multiple sclerosis: a model for MS susceptibility
por: Goodin, Douglas S
Publicado: (2010)

The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS
por: Martínez-Lapiscina, Elena H, et al.
Publicado: (2014)

Fluctuations of spontaneous EEG topographies predict disease state in relapsing-remitting multiple sclerosis
por: Gschwind, Markus, et al.
Publicado: (2016)

AZD-1222/elasomeran/tozinameran: Multiple sclerosis (MS) and relapse of MS: 16 case reports
Publicado: (2022)

Multiplicities, fluctuations and correlations
por: Sarkisyan-Grinbaum, E
Publicado: (2002)

Multiplicity, correlations, fluctuations
por: Bialas, A
Publicado: (1995)

An Objective Fluctuation Score for Parkinson's Disease
por: Horne, Malcolm K., et al.
Publicado: (2015)

Longitudinal Assessment of Antisaccades in Patients with Multiple Sclerosis
por: Fielding, Joanne, et al.
Publicado: (2012)

Longitudinal patterns of cortical thinning in multiple sclerosis
por: Tsagkas, Charidimos, et al.
Publicado: (2020)

A Risk Score for Predicting Multiple Sclerosis
por: Dobson, Ruth, et al.
Publicado: (2016)

Safety and patient experience with at‐home infusion of ocrelizumab for multiple sclerosis
por: Barrera, Britney, et al.
Publicado: (2023)

RAId_aPS: MS/MS Analysis with Multiple Scoring Functions and Spectrum-Specific Statistics
por: Alves, Gelio, et al.
Publicado: (2010)

Characteristics, comorbidities, and complications in multiple sclerosis (MS) and non-MS patients undergoing lumbar fusion for deformity
por: Sulovari, Aron, et al.
Publicado: (2023)

Global Barriers to the Diagnosis of Multiple Sclerosis: Data From the Multiple Sclerosis International Federation Atlas of MS, Third Edition
por: Solomon, Andrew J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_41ehk8eofvthgheegvgh366mfq